🇺🇸 FDA
Patent

US 9339491

Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease

granted A61KA61K31/415A61K9/0053

Quick answer

US patent 9339491 (Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease) held by MEREO BIOPHARMA 1 LIMITED expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MEREO BIOPHARMA 1 LIMITED
Grant date
Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/415, A61K9/0053, A61K9/20, A61P